cyc 202 has been researched along with nu2058 in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (nu2058) | Trials (nu2058) | Recent Studies (post-2010) (nu2058) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 28 | 0 | 11 |
| Protein | Taxonomy | cyc 202 (IC50) | nu2058 (IC50) |
|---|---|---|---|
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 7 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 7 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 7 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 7 | |
| Cyclin-A2 | Homo sapiens (human) | 7 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 7 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 7 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferguson, M; Fersht, A; Finlan, L; Hupp, TR; Ibbotson, S; Luciani, MG; Rankin, EM | 1 |
1 other study(ies) available for cyc 202 and nu2058
| Article | Year |
|---|---|
The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
Topics: Antineoplastic Agents; Binding Sites; CDC2-CDC28 Kinases; Cell Death; Cyclin A; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Guanine; Humans; Mutation; Peptide Fragments; Phosphorylation; Protein Binding; Purines; Roscovitine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2004 |